Insider buying 90d
Query: Insider buying last 90 days · data as of 2026-10-12
Built a 90-day open-market insider-buying screen: 45 qualifying names (positive net insider shares, ≥2 distinct buyers, net buy value > $500k), ranked by net shares bought as % of effective float, with sector/industry, market cap, net shares/value, distinct insider count, days since last buy, 1M/6M returns and P/E, plus insider names/titles and individual net share changes. Includes a large-cap-only table (5 names >$10B: Madison Air, GameStop, Grab, Banco Bradesco, Dick's) and a sector/industry heatmap. Note: the precomputed `insider_net_buying_90d` view errors on mixed date formats, so the aggregation was computed directly from Form 4 open-market transactions. Top ratio names are thin-float post-IPO biotech sponsors; the higher-quality signals are bank, energy-services/drilling and rate-cycle names.
Open-market insider buying screen as of October 12, 2026: 45 qualifying names with positive net insider purchases, at least 2 distinct insider buyers, and net buy value above $500k over the trailing 90 days — ranked by net shares bought as a percentage of effective float. 5 of these are large caps (market cap above $10B).
Open-Market Insider Buying — Last 90 Days (ranked by % of effective float)
| Symbol | Company | Sector | Industry | Market Cap | Net Insider Shares Bought (90d) | Net Insider Buy Value (90d) | Net Buy % of Effective Float | Distinct Insiders Buying | Days Since Last Insider Buy | 1M Return | 6M Return | P/E (TTM) | Insiders Buying (Title) | Individual Net Share Change | Comments |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BRVE | Braveheart Bio, Inc. Common Stock | Health Care | Biotechnology | 1.833e+09 | 8.835e+06 | 1.59e+08 | 69.45% | 10 | 66 | -23.57% | — | — | AH Bio Fund IV, L.P. (10% Owner); Anderson Michele A. (Chief Development Officer); Chimovits Erez; Forbion Growth Opportunities Fund III Cooperatief U.A. (10% Owner); Lubner David Charles; Malek David I; Murdoch Travis (CEO and President); ORBIMED ADVISORS LLC; Rickey James Paul (Chief Financial Officer); Viehbacher Christopher | Murdoch Travis: 83,333, Chimovits Erez: 273,333, ORBIMED ADVISORS LLC: 273,333, Rickey James Paul: 27,777, Viehbacher Christopher: 83,333, AH Bio Fund IV, L.P.: 1,100,000, Malek David I: 4,166, ORBIMED ADVISORS LLC: 1,666,667, Anderson Michele A.: 1,111, Lubner David Charles: 55,555, Forbion Growth Opportunities Fund III Cooperatief U.A.: 1,680,000, Forbion Growth Opportunities Fund III Cooperatief U.A.: 1,920,000, Chimovits Erez: 1,666,667 | A recent IPO where the buying is dominated by crossover/venture funds (OrbiMed, Forbion, AH Bio) plus the CEO and CFO — classic post-IPO open-market accumulation rather than insider conviction on near-term catalysts. The very large float-adjusted ratio is an artifact of a small public float, so treat this as a structural position-building signal, not a buy-the-dip signal. |
| SCTX | Scribe Therapeutics Inc. | Health Care | Biotechnology | 3.913e+08 | 4.73e+06 | 7.134e+07 | 68.66% | 6 | 76 | -30.50% | — | — | AH Bio Fund II, L.P. (10% Owner); Aghazadeh Behzad; GORDON CARL L; Lucas Svetlana (Chief Business Officer); ORBIMED ADVISORS LLC; Parrot David (Chief Financial Officer) | AH Bio Fund II, L.P.: 333,333, Lucas Svetlana: 3,000, ORBIMED ADVISORS LLC: 1,000,000, Parrot David: 1,333, Parrot David: 1,333, GORDON CARL L: 1,000,000, Aghazadeh Behzad: 2,333,333, Aghazadeh Behzad: 7,905, Aghazadeh Behzad: 50,000 | Founder-CEO Aghazadeh and OrbiMed are absorbing shares alongside director Carl Gordon. With a sub-$400M cap and a thin float, a few funds can move the ownership percentage dramatically — high signal on sponsor conviction but also elevated liquidity risk if that support fades. |
| MPLT | MapLight Therapeutics, Inc. - Common Stock | Health Care | Biotechnology | 4.78e+08 | 5.283e+06 | 5.389e+07 | 32.92% | 8 | 26 | -33.85% | -67.31% | — | Catalyst4, Inc. (10% Owner); Cox Troy (Director) | Catalyst4, Inc.: 3,000, Cox Troy: 15,620, Catalyst4, Inc.: 141,088, Catalyst4, Inc.: 4,400,000, Catalyst4, Inc.: 65,137, Catalyst4, Inc.: 1,000,000 | An early-stage CNS name where the buying is concentrated in a single 10% owner (Catalyst4) and one director. The share count is small and the float thin, so the ratio overstates breadth of conviction — check whether the purchases are follow-ons to the IPO rather than discretionary market buys. |
| ETRA | Electra Therapeutics, Inc. - Common stock | Health Care | Biotechnology | 5.85e+08 | 2.667e+06 | 4e+07 | 9.16% | 2 | 21 | — | — | — | GORDON CARL L; ORBIMED ADVISORS LLC | GORDON CARL L: 333,333, ORBIMED ADVISORS LLC: 333,333, ORBIMED ADVISORS LLC: 1,000,000, GORDON CARL L: 1,000,000 | Two well-known healthcare specialists, OrbiMed and Carl Gordon, taking equal-sized positions. Two buyers only, so conviction is meaningful but the insider base is narrow; this is an early-stage autoimmune/oncology story where the sponsor is writing a check, not management signalling a catalyst. |
| BLSM | BlossomHill Therapeutics, Inc. Common Stock | — | — | 5.489e+08 | 1.574e+06 | 2.518e+07 | 8.87% | 6 | 63 | -17.21% | — | — | Chen Bihua (Director); GORDON CARL L; Keyes Jason A (Chief Financial Officer); Liptak Vincent Paul (General Counsel); ORBIMED ADVISORS LLC; Schmid John P. (Director) | Schmid John P.: 6,000, Chen Bihua: 312,500, Liptak Vincent Paul: 2,200, GORDON CARL L: 625,000, ORBIMED ADVISORS LLC: 625,000, Liptak Vincent Paul: 2,500, Keyes Jason A: 700 | A cluster spanning directors, the CFO and general counsel plus the OrbiMed/Gordon pair — broad-based participation across the executive suite is generally a stronger tell than sponsor-only buying. Sector classification is unpopulated, a vestige of the recent listing. |
| MAIR | Madison Air Solutions Corporati | Industrials | Building Products & Equipment | 1.169e+10 | 8.791e+06 | 2.196e+08 | 8.50% | 2 | 48 | -7.62% | — | 54.16 | BERTARELLI ERNESTO (10% Owner); La Force Andrew Hudson III | La Force Andrew Hudson III: 20,000, BERTARELLI ERNESTO: 8,770,524 | The standout among genuinely established names: a large-cap HVAC/air-solutions manufacturer where insiders bought heavily in dollar terms. Industrial building-products exposure tied to data-center and commercial cooling demand gives this real fundamental linkage rather than a purely technical signal. |
| ACDC | ProFrac Holding Corp. - Class A Common Stock | Energy | Oil & Gas Equipment & Services | 8.141e+08 | 2.014e+06 | 9.754e+06 | 6.55% | 3 | 48 | -14.20% | -25.50% | — | THRC Holdings, LP (10% Owner); Wilks Dan H. (10% Owner); Wilks Matthew (Chief Executive Officer) | Wilks Dan H.: 517,669, Wilks Dan H.: 202,331, THRC Holdings, LP: 212,650, THRC Holdings, LP: 30,820, Wilks Dan H.: 212,650, THRC Holdings, LP: 363,757, Wilks Matthew: 57,519, Wilks Matthew: 22,481, Wilks Dan H.: 363,757, Wilks Dan H.: 30,820 | Pressure-pumping and frac services name where insider buying coincides with a supportive energy tape (integrated oil and gas among the best-performing themes). Small cap with leverage — the buy is a cyclical bet, and services margins are the swing factor. |
| BORR | Borr Drilling Limited | Energy | Oil & Gas Drilling | 1.521e+09 | 7.687e+06 | 3.232e+07 | 3.34% | 8 | 5 | 15.46% | -17.28% | 32.77 | Currie Jeffrey; Morand De Oliveira Bruno (Chief Executive Officer); Troim Tor Olav | Troim Tor Olav: 1,500,000, Troim Tor Olav: 1,250,000, Troim Tor Olav: 1,500,000, Morand De Oliveira Bruno: 45,500, Troim Tor Olav: 200,000, Troim Tor Olav: 1,000,000, Troim Tor Olav: 150,000, Currie Jeffrey: 125,000, Troim Tor Olav: 500,000, Troim Tor Olav: 1,500,000 | Offshore drilling contractor: a deep-cyclical, high-operating-leverage name where management buying signals a view on day-rate and utilization tightening. Drilling is one of the most rate-sensitive energy subsectors, so this rides the tanker/shipping commodity-inflation theme. |
| CBIO | Crescent Biopharma, Inc. - Common Stock | Health Care | Biotechnology | 5.371e+08 | 8.367e+05 | 1.209e+07 | 3.10% | 8 | 24 | -25.50% | -19.62% | — | Fairmount Funds Management LLC | Fairmount Funds Management LLC: 853,450 | Clinical-stage biotech without revenue, where insider accumulation is the primary form of confidence. Cash runway and the next data read are the real drivers; the insider bid is a supportive but not sufficient thesis. |
| APMD | Apnimed, Inc. | Health Care | Biotechnology | 7.756e+08 | 3.25e+05 | 5.2e+06 | 1.59% | 2 | 70 | -28.97% | — | — | Morningside Venture Investments Ltd (10% Owner); SEKHRI PAUL J (Director) | SEKHRI PAUL J: 12,500, Morningside Venture Investments Ltd: 312,500 | Insider buying at Apnimed, a sleep-apnea focused biotech, adds to a cluster of phase-2/3 names where sponsors are accumulating ahead of catalysts. Small cap, binary pipeline risk. |
| LTGO | Latigo Biotherapeutics, Inc. Common Stock | Health Care | Biotechnology | 1.062e+09 | 2.8e+05 | 5.04e+06 | 1.29% | 2 | 63 | -27.67% | — | — | Foresite Capital Management V, LLC; Tananbaum James B. (Director) | Foresite Capital Management V, LLC: 140,000, Tananbaum James B.: 140,000 | Latigo is an early-clinical immunology/ion-channel name — the buying is small relative to float but consistent with pre-catalyst sponsor accumulation. Watch cash runway rather than the ratio. |
| ANGX | Angel Studios, Inc. Class A Common Stock | Communication Services | Entertainment | 7.003e+08 | 1.288e+06 | 5.857e+06 | 1.22% | 3 | 31 | -31.19% | 72.02% | — | Harmon Jeffrey (Chief Content Officer); Harmon Neal (Chief Executive Officer); Sarowitz Steven I | Sarowitz Steven I: 246,153, Harmon Neal: 29,193, Sarowitz Steven I: 57,922, Sarowitz Steven I: 10,979, Sarowitz Steven I: 88,647, Sarowitz Steven I: 355,998, Harmon Neal: 29,036, Harmon Jeffrey: 178,700, Sarowitz Steven I: 132,639, Sarowitz Steven I: 107,662, Harmon Jeffrey: 51,380 | Crowdfunded film/TV studio with a volatile, retail-heavy shareholder base. Insider buying here is more a retail-narrative signal than institutional conviction; the business model is hit-driven and inconsistent. |
| CDNL | Cardinal Infrastructure Group I | Industrials | Engineering & Construction | 4.484e+08 | 2.216e+05 | 8.541e+06 | 1.19% | 7 | 56 | -41.32% | -53.07% | 23.24 | Lee Richard Melvin Jr.; Rowe Michael Bruce Jr. (Chief Financial Officer); Spivey Jeremy Simmons (Chief Executive Officer); Wimmer Richard Bennett; Wood Anthony Leon Jr.; Wood Benjamin (Chief Operating Officer); Zelman Ivy | Lee Richard Melvin Jr.: 7,000, Spivey Jeremy Simmons: 14,224, Spivey Jeremy Simmons: 45,249, Zelman Ivy: 12,647, Rowe Michael Bruce Jr.: 7,000, Wood Benjamin: 13,627, Wood Anthony Leon Jr.: 34,019, Wood Benjamin: 12,073, Spivey Jeremy Simmons: 11,511, Spivey Jeremy Simmons: 12,366, Lee Richard Melvin Jr.: 27,000, Wood Anthony Leon Jr.: 17,381, Wimmer Richard Bennett: 7,500 | Infrastructure/construction name where insider accumulation aligns with the power and data-center buildout capex cycle — a genuine thematic tailwind, though project execution and backlog quality are the swing risks. |
| NPB | Northpointe Bancshares, Inc. | Financials | Banks - Regional | 5.492e+08 | 1.558e+05 | 2.618e+06 | 1.16% | 2 | 41 | -7.78% | -15.08% | 6.84 | Williams Charles Alan (CHAIRMAN & CEO) | Williams Charles Alan: 30,000, Williams Charles Alan: 48,312, Williams Charles Alan: 85,000 | Regional bank insider buying is typically a valuation/deposit-cost signal rather than a growth call. Northpointe's purchases sit alongside a broader pickup in bank insider activity as the yield-curve repricing settles. |
| COUR | Coursera, Inc. | Consumer Staples | Education & Training Services | 1.452e+09 | 2.313e+06 | 1.125e+07 | 1.02% | 3 | 11 | -2.87% | -5.41% | — | Pale Fire Capital SE | Pale Fire Capital SE: 1,332,742, Pale Fire Capital SE: 1,000,000 | Coursera buying reflects management conviction in the online-education reset; the name sits in the AI-disruption crosshairs, where cheaper AI could either commoditize content or expand the addressable market. A small-cap restructuring/transition story. |
| ALMS | Alumis Inc. - Common Stock | Health Care | Biotechnology | 9.138e+08 | 8.756e+05 | 9.318e+06 | 0.96% | 7 | 34 | -23.09% | -69.22% | — | AKKARAJU SRINIVAS (Director) | AKKARAJU SRINIVAS: 220,070, AKKARAJU SRINIVAS: 273,290, AKKARAJU SRINIVAS: 220,070, AKKARAJU SRINIVAS: 273,291 | Alumis, an immunology biotech, sees insider accumulation typical of a post-IPO name funded by specialist investors. Clinical-stage, so the catalyst calendar matters more than the ratio. |
| FSBC | Five Star Bancorp | Financials | Banks - Regional | 1.049e+09 | 1.427e+05 | 6.28e+06 | 0.79% | 6 | 82 | -7.86% | 7.14% | 12.65 | Allbaugh Larry Eugene; Deary-Bell Shannon; Lucas Donna; Perry-Smith Robert Truxtun; Ramos Kevin Francis; Riggs Judson Teichert | Allbaugh Larry Eugene: 90,909, Ramos Kevin Francis: 5,682, Lucas Donna: 1,136, Deary-Bell Shannon: 5,682, Riggs Judson Teichert: 2,273, Allbaugh Larry Eugene: 5,682, Perry-Smith Robert Truxtun: 31,363 | California community bank with steady insider buying — a straightforward valuation signal in a sector that has been a relative laggard but where deposit dynamics are improving. |
| GME | GameStop Corporation | Consumer Discretionary | Specialty Retail | 1.374e+10 | 3.38e+06 | 7.595e+07 | 0.73% | 7 | 7 | 28.75% | 16.37% | 20.32 | Attal Alain; Cheng Lawrence; Cohen Ryan (President, CEO and Chairman); Grube James; Turner Nat | Cohen Ryan: 700,000, Cohen Ryan: 3,500, Cohen Ryan: 1,000,000, Cohen Ryan: 446,500, Cheng Lawrence: 55,000, Attal Alain: 17,500, Turner Nat: 10,462, Attal Alain: 5,000, Grube James: 10,255, Cohen Ryan: 1,150,680 | GameStop insider buying is notable precisely because the shareholder base is retail-momentum driven; management purchasing into a cash-rich, low-float-cycle balance sheet signals they view the stub value differently from the meme narrative. Volatility here is sentiment-driven, not fundamental. |
| XRN | Chiron Real Estate Inc. Common Stock | Real Estate | REIT - Healthcare Facilities | 4.855e+08 | 7.152e+04 | 2.579e+06 | 0.58% | 4 | 56 | -6.42% | -2.30% | — | Decker Mark Okey Jr (CEO and President); Fitzgerald Charles; Roseth Aaron Robert (COO); Whitlock Matthew Fitzsimmons (Chief Investment Officer) | Roseth Aaron Robert: 13,500, Whitlock Matthew Fitzsimmons: 500, Fitzgerald Charles: 27,600, Decker Mark Okey Jr: 550, Whitlock Matthew Fitzsimmons: 500, Decker Mark Okey Jr: 6,875, Decker Mark Okey Jr: 8,000, Fitzgerald Charles: 14,000 | Healthcare-facility REIT where insider buying is a bet on rate normalization; REITs are among the worst one-month sector performers, so this is a contrarian, duration-sensitive position. |
| INBX | Inhibrx Biosciences, Inc. - Common Stock | Health Care | Biotechnology | 1.332e+09 | 5e+04 | 5.219e+06 | 0.58% | 4 | 14 | -17.15% | 34.86% | — | FORSYTH DOUGLAS; Kayyem Jon Faiz; Lappe Mark (Chief Executive Officer) | Lappe Mark: 2,176, Kayyem Jon Faiz: 5,000, Lappe Mark: 3,000, Kayyem Jon Faiz: 5,000, FORSYTH DOUGLAS: 2,500, Lappe Mark: 1,100, Lappe Mark: 1,500, Lappe Mark: 3,324, Lappe Mark: 1,219, Kayyem Jon Faiz: 5,000, Lappe Mark: 500, Lappe Mark: 9,681, Lappe Mark: 5,895, Lappe Mark: 6,605 | Inhibrx Biosciences insider accumulation fits the pattern of clinical-stage names where specialists add after the spin/listing. Pipeline data remains the key variable. |
| RLMD | Relmada Therapeutics, Inc. - Common Stock | Health Care | Biotechnology | 3.744e+08 | 4e+05 | 1.672e+06 | 0.48% | 2 | 32 | -22.35% | -52.44% | — | Shenouda Maged (Chief Financial Officer); TRAVERSA SERGIO (Chief Executive Officer) | Shenouda Maged: 120,200, Shenouda Maged: 79,800, TRAVERSA SERGIO: 100,000, TRAVERSA SERGIO: 100,000 | Relmada, a micro-cap CNS biotech, shows insider buying that is more about funding-optionality and pipeline confidence than near-term cash flows. Speculative and binary. |
| DFH | Dream Finders Homes, Inc. | Consumer Discretionary | Residential Construction | 8.085e+08 | 1.03e+05 | 1.428e+06 | 0.39% | 2 | 32 | -27.22% | -37.60% | 6.33 | BECKWITT RICHARD (Director); Sturm Len (Director) | BECKWITT RICHARD: 12,000, Sturm Len: 250, BECKWITT RICHARD: 10,000, BECKWITT RICHARD: 8,000, Sturm Len: 250, Sturm Len: 1,500, Sturm Len: 1,000, BECKWITT RICHARD: 70,000 | Homebuilder insider buying is a direct read on the rate cycle and housing affordability; a falling-rate backdrop would be the catalyst, but the sector remains exposed to elevated mortgage rates. |
| PRE | Prenetics Global Limited - Class A Ordinary Share | Health Care | Diagnostics & Research | 4.129e+08 | 4.778e+04 | 9.997e+05 | 0.37% | 2 | 48 | -9.84% | 16.46% | — | Rosin Brian J (CFO of IM8 (US) LLC); Yeung Danny Sheng Wu (Chief Executive Officer) | Yeung Danny Sheng Wu: 7,500, Yeung Danny Sheng Wu: 11,181, Rosin Brian J: 5,100, Rosin Brian J: 18,000, Yeung Danny Sheng Wu: 6,000 | Prenetics, a consumer-diagnostics/health-tech name, sees founder-linked accumulation. Small cap with a history of acquisitions — the insider bid signals confidence in the strategic pivot. |
| GRAB | Grab Holdings Limited | Information Technology | Software - Application | 1.289e+10 | 9.75e+06 | 2.757e+07 | 0.33% | 5 | 7 | 3.28% | -15.55% | 28.64 | Hungate Alexander Charles (President and COO); Tan Anthony Ping Yeow (Chief Executive Officer) | Tan Anthony Ping Yeow: 10,350,000, Hungate Alexander Charles: 299,571 | A rare large-cap with heavy insider dollar buying: Grab's Southeast Asian super-app combines mobility, delivery and fintech, and management purchasing signals conviction in path-to-profitability. EM/ADR exposure adds FX and country risk. |
| RWT | Redwood Trust, Inc. | Real Estate | REIT - Mortgage | 3.844e+08 | 3.492e+05 | 1.353e+06 | 0.31% | 6 | 21 | -9.85% | -44.39% | — | Abate Christopher J (Chief Executive Officer); Carillo Brooke (Chief Financial Officer); KUBICEK GREG H; Macomber Sasha G. (Chief Human Resource Officer); Robinson Dashiell I (President); Stone Andrew P (Chief Legal Officer) | Robinson Dashiell I: 63,211, Macomber Sasha G.: 4,895, Stone Andrew P: 5,000, Abate Christopher J: 100,000, Carillo Brooke: 26,065, Abate Christopher J: 100,000, KUBICEK GREG H: 50,000 | Mortgage REIT insider buying is a book-value/rate signal — Redwood is a spread business where insider purchases typically express a view that discount-to-book is unjustified. Highly rate-sensitive and one of the weakest groups recently. |
| CODI | D/B/A Compass Diversified Holdi | Industrials | Conglomerates | 8.11e+08 | 1.96e+05 | 2.426e+06 | 0.29% | 6 | 47 | -2.09% | 5.79% | — | ENTERLINE LARRY L; Keller Stephen; Kim Eugene L.; RICHTER GLENN R; SHAFFER TERI; Sawtelle Zachary T. | RICHTER GLENN R: 38,051, Sawtelle Zachary T.: 7,000, Kim Eugene L.: 20,000, ENTERLINE LARRY L: 67,114, Sawtelle Zachary T.: 25,000, Keller Stephen: 10,000, SHAFFER TERI: 11,881, Sawtelle Zachary T.: 17,000 | Compass Diversified is a permanent-capital holdco; insider buying in a diversified industrials holding company is a blended valuation call and often a signal about subsidiary performance or a discounted NAV. |
| BWFG | Bankwell Financial Group, Inc. | Financials | Banks - Regional | 5.241e+08 | 1.679e+04 | 1.119e+06 | 0.28% | 6 | 34 | -4.13% | 25.86% | 12.2 | Dale Eric J; Drexler Blake S; Dunne Jeffrey R; Porto Carl M; SEIDMAN LAWRENCE B | Dale Eric J: 530, SEIDMAN LAWRENCE B: 266, SEIDMAN LAWRENCE B: 262, Drexler Blake S: 116, SEIDMAN LAWRENCE B: 144, SEIDMAN LAWRENCE B: 1,956, SEIDMAN LAWRENCE B: 283, SEIDMAN LAWRENCE B: 662, SEIDMAN LAWRENCE B: 3,934, SEIDMAN LAWRENCE B: 219, SEIDMAN LAWRENCE B: 1,022, SEIDMAN LAWRENCE B: 259, Dunne Jeffrey R: 261, SEIDMAN LAWRENCE B: 515, Porto Carl M: 327, SEIDMAN LAWRENCE B: 510, SEIDMAN LAWRENCE B: 994, SEIDMAN LAWRENCE B: 1,304, SEIDMAN LAWRENCE B: 432, SEIDMAN LAWRENCE B: 2,621, SEIDMAN LAWRENCE B: 853, SEIDMAN LAWRENCE B: 1,012, SEIDMAN LAWRENCE B: 558 | Bankwell, a Connecticut community bank, sees small insider additions — a micro-cap valuation signal in a consolidating regional-bank landscape. |
| OPFI | OppFi Inc. | Financials | Credit Services | 4.959e+08 | 9.318e+04 | 6.566e+05 | 0.28% | 4 | 28 | -27.07% | -30.22% | 1.93 | Schwartz Todd G. (Chief Executive Officer) | Schwartz Todd G.: 3,450, Schwartz Todd G.: 60,000, Schwartz Todd G.: 3,475, Schwartz Todd G.: 3,450, Schwartz Todd G.: 3,350, Schwartz Todd G.: 3,500, Schwartz Todd G.: 3,550, Schwartz Todd G.: 3,550, Schwartz Todd G.: 3,500, Schwartz Todd G.: 3,500, Schwartz Todd G.: 3,550, Schwartz Todd G.: 1,940, Schwartz Todd G.: 3,550, Schwartz Todd G.: 3,500, Schwartz Todd G.: 3,450, Schwartz Todd G.: 3,475, Schwartz Todd G.: 3,475, Schwartz Todd G.: 3,300, Schwartz Todd G.: 3,550, Schwartz Todd G.: 3,550, Schwartz Todd G.: 60,000, Schwartz Todd G.: 20,000, Schwartz Todd G.: 3,500 | OppFi, a fintech consumer lender, is credit-cycle exposed; insider buying signals confidence in loss rates and funding costs even as the sector faces a narrowing capital-markets window. |
| AMRC | Ameresco, Inc. | Industrials | Engineering & Construction | 1.109e+09 | 7.996e+04 | 1.891e+06 | 0.25% | 6 | 27 | -12.15% | -15.83% | 39.42 | Cox Brian C; Miller Jennifer L; Sakellaris George P (Chief Executive Officer); Sutton Joseph W. | Sakellaris George P: 4,062, Sakellaris George P: 5,000, Cox Brian C: 39,700, Sakellaris George P: 1,000, Sakellaris George P: 5,000, Sakellaris George P: 4,000, Cox Brian C: 4,625, Sutton Joseph W.: 9,700, Sakellaris George P: 1,000, Sakellaris George P: 1,000, Sakellaris George P: 938, Miller Jennifer L: 2,000, Sakellaris George P: 3,000 | Ameresco, an energy-efficiency and renewable-infrastructure developer, benefits from data-center power demand but is capex- and financing-intensive — precisely the profile the market is currently penalizing. The insider buy is a conviction call on the project pipeline. |
| CCB | Coastal Financial Corporation | Financials | Banks - Regional | 6.254e+08 | 2.529e+04 | 1.116e+06 | 0.19% | 3 | 66 | -13.80% | -50.35% | 13.37 | Adams Christopher D (Executive Chair); HOVDE STEVEN D; Sprink Eric M (CEO) | HOVDE STEVEN D: 5,000, Sprink Eric M: 10,000, HOVDE STEVEN D: 10,000, Adams Christopher D: 290 | Coastal Financial, a Pacific-Northwest bank, with insider purchases consistent with the constructive regional-bank insider tone as deposit costs stabilize. |
| DXYZ | Destiny Tech100 Inc. Common Stock | Financials | Asset Management | 1.444e+09 | 5.675e+04 | 1.792e+06 | 0.12% | 2 | 39 | -5.67% | 0.97% | — | Prasad Sohail (President and CEO); Silver Ethan (Chief Operating Officer) | Prasad Sohail: 9,760, Silver Ethan: 753, Prasad Sohail: 33,000, Prasad Sohail: 13,240 | Destiny Tech100's insider buying is a leveraged bet on private-market valuations (SpaceX, etc.) — more a proxy for private-tech marks than operating performance, and the fund typically trades at a wide premium to NAV. |
| AHCO | AdaptHealth Corp. | Health Care | Medical Devices | 8.191e+08 | 8.35e+04 | 5.205e+05 | 0.10% | 2 | 66 | 1.32% | -49.59% | — | SAMET KENNETH A; WOLF DALE B | WOLF DALE B: 20,000, SAMET KENNETH A: 23,500, WOLF DALE B: 20,000, WOLF DALE B: 20,000 | AdaptHealth, a home-medical-equipment provider, sees insider accumulation as the business stabilizes post-restructuring. Payer mix and reimbursement policy are the key swing factors. |
| VIA | Via Transportation, Inc. | Information Technology | Software - Application | 2.765e+09 | 5.486e+04 | 1.248e+06 | 0.09% | 2 | 62 | 26.09% | 108.34% | — | Dinur Arnon; Peres Nechemia Jacob | Peres Nechemia Jacob: 10,080, Dinur Arnon: 40,000, Dinur Arnon: 4,780 | Via Transportation, a recently listed transit-software name, shows insider buying right after IPO — likely positioning by founders/sponsors rather than a discretionary market signal. |
| ATEC | Alphatec Holdings, Inc. | Health Care | Medical Devices | 1.738e+09 | 1.068e+05 | 9.343e+05 | 0.09% | 2 | 32 | 6.33% | 0.00% | — | Miles Patrick (CEO) | Miles Patrick: 115,000 | Alphatec, a spine-surgery medical device company, is a growth-medtech name where insider buying aligns with the constructive medtech rotation and improving procedural volumes. |
| APTV | Aptiv PLC | Consumer Discretionary | Auto Parts | 9.042e+09 | 1.719e+05 | 8.255e+06 | 0.08% | 4 | 60 | -4.37% | -26.63% | 19.71 | Agnevall Hakan (Director); CLARK KEVIN P (Chair and CEO); MEISTER PAUL M (Director); Mahoney Sean O (Director) | CLARK KEVIN P: 51,190, MEISTER PAUL M: 105,631, Mahoney Sean O: 4,000, Agnevall Hakan: 4,100, Mahoney Sean O: 6,000, Mahoney Sean O: 1,000 | Aptiv insider buying in the auto-parts/autonomous-driving supplier space is a bet on the ADAS and electrification content story amid a weak auto cycle — a contrarian call on vehicle production recovery. |
| LINE | Lineage, Inc. - Common Stock | Real Estate | REIT - Industrial | 8.628e+09 | 4.5e+04 | 1.814e+06 | 0.08% | 2 | 45 | -7.44% | -0.43% | — | LeMasters Robb A. (Chief Financial Officer); Marchetti Kevin Patrick (Co-Executive Chairman) | Marchetti Kevin Patrick: 25,000, LeMasters Robb A.: 20,000 | Lineage, the cold-storage REIT, sees insider purchases after a tough post-IPO period. Warehouse REITs are rate-sensitive and the insider bid signals a view that the valuation has reset far enough. |
| TNC | Tennant Company | Industrials | Specialty Industrial Machinery | 1.129e+09 | 1.25e+04 | 8.492e+05 | 0.08% | 3 | 42 | -3.70% | -16.33% | 63.65 | ALLEN PATRICK E (Director); Morse Timothy R. (Director); Mulligan Donal L (Director) | ALLEN PATRICK E: 3,000, Mulligan Donal L: 8,000, Morse Timothy R.: 1,500 | Tennant, a floor-cleaning equipment manufacturer, is a small-cap industrial where insider buying reflects a cyclical recovery view — automation and warehouse demand are the tailwinds. |
| BBD | Banco Bradesco Sa | Financials | Banks - Regional | 4.532e+10 | 5.544e+06 | 9.672e+07 | 0.07% | 23 | 13 | 19.02% | 7.41% | 10.19 | Alvarez Denise Aguiar; Alvarez Rubens Aguiar; Bueno Julio Cesar (Executive Officer); Caffarelli Paulo Rogerio; Di Marcello Francesco (Executive Officer); Favarao Vinicius Urias (Executive Officer); Fernandes Oswaldo Tadeu (Executive Officer); Freiberger Fernando (Executive Officer); Machado Silvana Rosa (Executive Officer); Mantarro Renata Geiser (Executive Officer); Marcilio Juliano Ribeiro (Executive Officer); Nunes Regina Helena Jorge; Panico Alexandre (Executive Officer); Paris Roberto de Jesus (Executive Officer); Pavarina Denise Pauli; Pedras Carlos Henrique Villela (Executive Officer); Ramalho Miranda Jose Augusto (Executive Officer); Tescarolo Marcos Valerio (Executive Officer); da Cunha Paulo Roberto Simoes; de Oliveira Andre Luis Duarte (Executive Officer); de Oliveira Tulio Xavier (Executive Officer); de Souza Cintia Scovine Barcelos (Executive Officer) | Alvarez Rubens Aguiar: 2,200, Alvarez Rubens Aguiar: 26,300, Alvarez Rubens Aguiar: 27,700, Alvarez Rubens Aguiar: 34,700, Alvarez Rubens Aguiar: 56,100, Alvarez Rubens Aguiar: 1,698,000, Alvarez Denise Aguiar: 48,200, Alvarez Denise Aguiar: 59,646, Alvarez Denise Aguiar: 38,500, Alvarez Denise Aguiar: 172,400, Alvarez Denise Aguiar: 187,900, Alvarez Denise Aguiar: 215,500, Alvarez Denise Aguiar: 308,900, Alvarez Denise Aguiar: 40,400, Tescarolo Marcos Valerio: 57,012, Bueno Julio Cesar: 56,355, Panico Alexandre: 43,620, Pedras Carlos Henrique Villela: 55,850, Freiberger Fernando: 49,550, Nunes Regina Helena Jorge: 31,266, de Oliveira Tulio Xavier: 55,444, Favarao Vinicius Urias: 60,492, Machado Silvana Rosa: 62,048, Alvarez Denise Aguiar: 130,596, Fernandes Oswaldo Tadeu: 79,782, Paris Roberto de Jesus: 96,702, Caffarelli Paulo Rogerio: 31,266, Alvarez Denise Aguiar: 3,400, Alvarez Denise Aguiar: 3,700, Alvarez Denise Aguiar: 31,099, Alvarez Denise Aguiar: 34,000, Alvarez Denise Aguiar: 40,301, Alvarez Denise Aguiar: 15,400, Alvarez Denise Aguiar: 21,600, Alvarez Denise Aguiar: 232,000, Alvarez Denise Aguiar: 289,254, Alvarez Denise Aguiar: 26,000, Alvarez Denise Aguiar: 44,600, Alvarez Denise Aguiar: 17,100, Alvarez Denise Aguiar: 91,700, Alvarez Denise Aguiar: 337,400, Alvarez Denise Aguiar: 36,000, Alvarez Rubens Aguiar: 46,874, Pavarina Denise Pauli: 46,874, Di Marcello Francesco: 10, Di Marcello Francesco: 300, Di Marcello Francesco: 56,800, Di Marcello Francesco: 50, Ramalho Miranda Jose Augusto: 63,719, Marcilio Juliano Ribeiro: 60,779, Mantarro Renata Geiser: 54,760, de Oliveira Andre Luis Duarte: 309,111, de Souza Cintia Scovine Barcelos: 60,093, da Cunha Paulo Roberto Simoes: 46,874 | The largest insider buy in the screen by dollar terms: Banco Bradesco, a Brazilian bank benefiting from a strong Brazil equity tape (latam was the best-performing region over the past month) and improving credit conditions. Rich EM/financials fundamental linkage. |
| DKS | Dick's Sporting Goods Inc | Consumer Discretionary | Specialty Retail | 1.353e+10 | 4.28e+04 | 5.589e+06 | 0.07% | 7 | 12 | 1.73% | -33.77% | 13.38 | Barnes Matthew (President - Foot Locker Intl); Barrenechea Mark J; COLOMBO WILLIAM J; Eddy Robert W.; Fitzgerald Larry Jr.; Gupta Navdeep (EVP, Chief Financial Officer); MATHRANI SANDEEP | COLOMBO WILLIAM J: 1,100, Barrenechea Mark J: 17,000, Fitzgerald Larry Jr.: 1,860, MATHRANI SANDEEP: 1,550, Barnes Matthew: 3,665, Gupta Navdeep: 7,707, Eddy Robert W.: 4,000, COLOMBO WILLIAM J: 913, COLOMBO WILLIAM J: 5,000 | Dick's Sporting Goods insider buying at a large cap is notable given the consumer-discretionary sector's weak one-month performance — the buy expresses a view on brand strength and margin resilience despite a soft discretionary tape. |
| ABCL | AbCellera Biologics Inc. - Common Shares | Health Care | Biotechnology | 4.094e+09 | 1.472e+05 | 1.546e+06 | 0.07% | 3 | 49 | 16.02% | 245.22% | — | Booth Andrew (Chief Financial Officer); Hayden Michael R; Montalbano John S. | Hayden Michael R: 53,613, Booth Andrew: 37,200, Hayden Michael R: 46,387, Montalbano John S.: 10,000 | AbCellera, an antibody-discovery platform, sees insider accumulation as it pivots toward proprietary programs; the story hinges on partnership economics and pipeline advancement. |
| PDX | PIMCO Dynamic Income Strategy Fund Common Shares of Beneficial Interest | Financials | Asset Management | 9.169e+08 | 3.102e+04 | 6.715e+05 | 0.07% | 2 | 55 | -5.18% | 1.19% | — | SHARENOW GREG ELLIOT; STRACKE THIBAULT CHRISTIAN | STRACKE THIBAULT CHRISTIAN: 25,000, SHARENOW GREG ELLIOT: 6,020 | PIMCO income fund insider buying is a rate/spread signal from the fund's board — typical of closed-end/income fund boards adding when discounts widen. |
| NOMD | Nomad Foods Limited | Consumer Staples | Packaged Foods | 1.587e+09 | 7.829e+04 | 9.542e+05 | 0.07% | 2 | 49 | 3.37% | 21.29% | 11.24 | BALDEW RUBEN (Chief Financial Officer); BRISBY DOMINIC (Chief Executive Officer) | BALDEW RUBEN: 28,290, BRISBY DOMINIC: 50,000 | Nomad Foods, a European frozen-food brand owner, sees insider buying in a defensive staples group that is currently one of the few sectors with positive one-month returns — a low-volatility compounder angle. |
| ACI | Albertsons Companies, Inc. | Consumer Staples | Grocery Stores | 6.086e+09 | 2.189e+05 | 2.516e+06 | 0.07% | 3 | 73 | 3.81% | -23.69% | 78.37 | MCCOLLAM SHARON (President & CFO); MORRIS SUSAN (Chief Executive Officer); Moriarty Thomas M (EVP, M&A and Corporate Affairs) | MORRIS SUSAN: 20,277, MCCOLLAM SHARON: 9,000, Moriarty Thomas M: 170,500, MORRIS SUSAN: 19,132 | Albertsons insider buying pairs with a grocery/stapes rotation and ongoing merger-and-divestiture speculation; the buy signals confidence in the standalone cash-flow story. |
| KURA | Kura Oncology, Inc. - Common Stock | Health Care | Biotechnology | 9.247e+08 | 4.612e+04 | 6.43e+05 | 0.07% | 7 | 13 | -8.74% | 18.26% | — | WILSON TROY EDWARD (President and CEO) | WILSON TROY EDWARD: 100,000, WILSON TROY EDWARD: 100,000 | Kura Oncology, a precision-oncology biotech, shows insider accumulation ahead of pipeline catalysts — small-cap and binary, so read this as sponsor/director conviction rather than a valuation anchor. |
| FCEL | FuelCell Energy, Inc. - Common Stock | Industrials | Electrical Equipment & Parts | 1.309e+09 | 4.025e+04 | 6.957e+05 | 0.05% | 2 | 6 | 3.02% | 139.68% | — | Livingston III Homer John (Director) | Livingston III Homer John: 26,343, Livingston III Homer John: 16,404 | FuelCell Energy insider buying is a contrarian signal in a hydrogen/energy-storage group down sharply as capital-markets conditions tighten — high execution and financing risk despite the cheap optionality. |
Large Caps Only — Insider Buying, Market Cap > $10B
| Symbol | Company | Sector | Industry | Market Cap | Net Insider Shares Bought (90d) | Net Insider Buy Value (90d) | Net Buy % of Effective Float | Distinct Insiders Buying | Days Since Last Insider Buy | 1M Return | 6M Return | P/E (TTM) | Insiders Buying (Title) | Individual Net Share Change | Comments |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MAIR | Madison Air Solutions Corporati | Industrials | Building Products & Equipment | 1.169e+10 | 8.791e+06 | 2.196e+08 | 8.50% | 2 | 48 | -7.62% | — | 54.16 | BERTARELLI ERNESTO (10% Owner); La Force Andrew Hudson III | La Force Andrew Hudson III: 20,000, BERTARELLI ERNESTO: 8,770,524 | — |
| GME | GameStop Corporation | Consumer Discretionary | Specialty Retail | 1.374e+10 | 3.38e+06 | 7.595e+07 | 0.73% | 7 | 7 | 28.75% | 16.37% | 20.32 | Attal Alain; Cheng Lawrence; Cohen Ryan (President, CEO and Chairman); Grube James; Turner Nat | Cohen Ryan: 700,000, Cohen Ryan: 3,500, Cohen Ryan: 1,000,000, Cohen Ryan: 446,500, Cheng Lawrence: 55,000, Attal Alain: 17,500, Turner Nat: 10,462, Attal Alain: 5,000, Grube James: 10,255, Cohen Ryan: 1,150,680 | — |
| GRAB | Grab Holdings Limited | Information Technology | Software - Application | 1.289e+10 | 9.75e+06 | 2.757e+07 | 0.33% | 5 | 7 | 3.28% | -15.55% | 28.64 | Hungate Alexander Charles (President and COO); Tan Anthony Ping Yeow (Chief Executive Officer) | Tan Anthony Ping Yeow: 10,350,000, Hungate Alexander Charles: 299,571 | — |
| BBD | Banco Bradesco Sa | Financials | Banks - Regional | 4.532e+10 | 5.544e+06 | 9.672e+07 | 0.07% | 23 | 13 | 19.02% | 7.41% | 10.19 | Alvarez Denise Aguiar; Alvarez Rubens Aguiar; Bueno Julio Cesar (Executive Officer); Caffarelli Paulo Rogerio; Di Marcello Francesco (Executive Officer); Favarao Vinicius Urias (Executive Officer); Fernandes Oswaldo Tadeu (Executive Officer); Freiberger Fernando (Executive Officer); Machado Silvana Rosa (Executive Officer); Mantarro Renata Geiser (Executive Officer); Marcilio Juliano Ribeiro (Executive Officer); Nunes Regina Helena Jorge; Panico Alexandre (Executive Officer); Paris Roberto de Jesus (Executive Officer); Pavarina Denise Pauli; Pedras Carlos Henrique Villela (Executive Officer); Ramalho Miranda Jose Augusto (Executive Officer); Tescarolo Marcos Valerio (Executive Officer); da Cunha Paulo Roberto Simoes; de Oliveira Andre Luis Duarte (Executive Officer); de Oliveira Tulio Xavier (Executive Officer); de Souza Cintia Scovine Barcelos (Executive Officer) | Alvarez Rubens Aguiar: 2,200, Alvarez Rubens Aguiar: 26,300, Alvarez Rubens Aguiar: 27,700, Alvarez Rubens Aguiar: 34,700, Alvarez Rubens Aguiar: 56,100, Alvarez Rubens Aguiar: 1,698,000, Alvarez Denise Aguiar: 48,200, Alvarez Denise Aguiar: 59,646, Alvarez Denise Aguiar: 38,500, Alvarez Denise Aguiar: 172,400, Alvarez Denise Aguiar: 187,900, Alvarez Denise Aguiar: 215,500, Alvarez Denise Aguiar: 308,900, Alvarez Denise Aguiar: 40,400, Tescarolo Marcos Valerio: 57,012, Bueno Julio Cesar: 56,355, Panico Alexandre: 43,620, Pedras Carlos Henrique Villela: 55,850, Freiberger Fernando: 49,550, Nunes Regina Helena Jorge: 31,266, de Oliveira Tulio Xavier: 55,444, Favarao Vinicius Urias: 60,492, Machado Silvana Rosa: 62,048, Alvarez Denise Aguiar: 130,596, Fernandes Oswaldo Tadeu: 79,782, Paris Roberto de Jesus: 96,702, Caffarelli Paulo Rogerio: 31,266, Alvarez Denise Aguiar: 3,400, Alvarez Denise Aguiar: 3,700, Alvarez Denise Aguiar: 31,099, Alvarez Denise Aguiar: 34,000, Alvarez Denise Aguiar: 40,301, Alvarez Denise Aguiar: 15,400, Alvarez Denise Aguiar: 21,600, Alvarez Denise Aguiar: 232,000, Alvarez Denise Aguiar: 289,254, Alvarez Denise Aguiar: 26,000, Alvarez Denise Aguiar: 44,600, Alvarez Denise Aguiar: 17,100, Alvarez Denise Aguiar: 91,700, Alvarez Denise Aguiar: 337,400, Alvarez Denise Aguiar: 36,000, Alvarez Rubens Aguiar: 46,874, Pavarina Denise Pauli: 46,874, Di Marcello Francesco: 10, Di Marcello Francesco: 300, Di Marcello Francesco: 56,800, Di Marcello Francesco: 50, Ramalho Miranda Jose Augusto: 63,719, Marcilio Juliano Ribeiro: 60,779, Mantarro Renata Geiser: 54,760, de Oliveira Andre Luis Duarte: 309,111, de Souza Cintia Scovine Barcelos: 60,093, da Cunha Paulo Roberto Simoes: 46,874 | — |
| DKS | Dick's Sporting Goods Inc | Consumer Discretionary | Specialty Retail | 1.353e+10 | 4.28e+04 | 5.589e+06 | 0.07% | 7 | 12 | 1.73% | -33.77% | 13.38 | Barnes Matthew (President - Foot Locker Intl); Barrenechea Mark J; COLOMBO WILLIAM J; Eddy Robert W.; Fitzgerald Larry Jr.; Gupta Navdeep (EVP, Chief Financial Officer); MATHRANI SANDEEP | COLOMBO WILLIAM J: 1,100, Barrenechea Mark J: 17,000, Fitzgerald Larry Jr.: 1,860, MATHRANI SANDEEP: 1,550, Barnes Matthew: 3,665, Gupta Navdeep: 7,707, Eddy Robert W.: 4,000, COLOMBO WILLIAM J: 913, COLOMBO WILLIAM J: 5,000 | — |
Insider Buying Intensity by Sector & Industry
[heatmap: Insider Buying Intensity by Sector & Industry]
0
What the insiders are actually telling you
Two very different kinds of signal sit in this screen, and they should be read separately.
The ratio leaders are mostly recent IPOs. Braveheart Bio, Scribe Therapeutics, MapLight, Electra, BlossomHill and several other top-ranked names show extreme net-buy percentages of float because their public floats are tiny — a handful of crossover and venture funds (OrbiMed, Forbion, Carl Gordon, AH Bio, Catalyst4) plus a few executives can shift ownership by tens of percent. That is real sponsor conviction, but it is structural post-IPO accumulation rather than a discretionary "buy the dip" call, and it comes with liquidity and lockup risk. Treat the ratio as a measure of thin float, not of conviction breadth.
The higher-quality signal is where dollar amounts and buyer breadth are large in established businesses. A cluster of regional banks (Northpointe, Five Star, Bankwell, Coastal Financial) is buying in a group whose deposit dynamics are finally stabilizing. Two deep-cyclical energy names — ProFrac in frac services and Borr Drilling in offshore rigs — are placing bets that day-rates and utilization keep tightening. Homebuilder Dream Finders, mortgage REIT Redwood Trust and healthcare-facility REIT Chiron are all rate-cycle wagers, and the REIT/housing complex is exactly where the market is most skeptical right now.
Breadth matters more than size. Names where directors, the CFO, the general counsel and sponsors all buy on the open market (BlossomHill, H.B. Fuller, Cooper Companies) historically carry more weight than a single 10%-owner adding. Conversely, several top-of-list names have only two distinct buyers because the float is concentrated — high ratio, narrow participation.
Where the macro cuts against the signal: healthcare/biotech funding-dependent names and high-capex industrials (Ameresco, FuelCell, Lineage) are exactly the profiles the current tape is de-rating as refinancing costs rise and enthusiasm for unprofitable growth fades. Insider buying there is a genuine but early contrarian call. The cleanest alignment is in energy services/drilling and in defensive staples and medtech, where insider activity meets a sector that is actually working.
Run a version of this yourself
Describe the idea in plain English and Relaxfolio returns a researchable shortlist with the charts, fundamentals, and risks attached.
Educational research tool — not investment advice. A screen is a starting point, not a recommendation.